Targeting nitric oxide in the adjuvant therapy of sepsis and meningitis

Journal of Infectious Diseases

Volumn 177, Issue 3, 1998, Pages 766-769

  Shenep, Jerry L ^a   Tuomanen, Elaine ^b  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE; NITRIC OXIDE SYNTHASE; ANTIINFECTIVE AGENT;

DRUG EFFECT; ENZYME ANALYSIS; ENZYME INDUCTION; HOST RESISTANCE; HUMAN; MACROPHAGE; MENINGITIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; SEPSIS; ANIMAL; BIOLOGICAL MODEL; IMMUNOLOGY; METABOLISM;

ANIMALS; ANTI-INFECTIVE AGENTS; ENZYME INDUCTION; HUMANS; MACROPHAGES; MENINGITIS; MODELS, IMMUNOLOGICAL; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; SEPSIS;

EID: 0032014992     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/514251     Document Type: Review

References (3)

1. Katsuki S, Arnold W, Mittal C, et al. Stimulation of guanylate cyclase by sodium nitroprusside, nitroglycerin and nitric oxide in various tissue preparations and comparison to the effects of sodium azide and hydroxylamine. J Cyclic Nucleotide Res 1977;3:23-5.
2. Freeman G, Dyer RL, Juhos LT, St. John GA, Anbar M. Identification of nitric oxide (NO) in human blood. Arch Environ Health 1978;33:19-23.
3. 3 into nitrate is enhanced by endotoxin treatment. Proc Natl Acad Sci USA 1983;80:4518-21.